Literature DB >> 9872657

In vivo cyclin E expression as a marker for early cervical neoplasia.

B J Quade1, J J Park, C P Crum, D Sun, A Dutta.   

Abstract

Identification of human papillomavirus (HPV)-related early cervical neoplasia and its distinction from benign epithelial alterations is based on either subjectively applied morphologic criteria or on identification of associated papillomaviruses. The direct and indirect consequences of HPV infection, however, potentially include upregulation of some host genes. We investigated one candidate, cyclin E, as a possible marker for HPV-related early squamous lesions. Serial paraffin sections from 92 archival cervical biopsy specimens were analyzed, including 19 non-neoplastic biopsy specimens, 30 low-grade and 31 high-grade squamous intraepithelial lesions (SILs), and 12 invasive carcinomas. Four parameters (histologic diagnosis, cyclin E staining, HPV status and, in selected cases, Ki-67 staining) were scored, and their relationship(s) were evaluated by the chi2 independence test. Twenty-one, 73, 79, and 75% of nonlesional epithelia, low-grade SILs, high-grade SILs, and invasive squamous cell carcinomas, respectively, were HPV positive (P < .001 for HPV status vs. diagnosis). Cyclin E staining was nuclear in distribution, and the frequency of positive staining, ie., moderate or strong intensity, was significantly higher (P < .001 for cyclin E staining vs. diagnosis) in all of the lesional epithelia (92.3, 51.6, and 50% of low-grade and high-grade SILs and carcinomas, respectively) compared with nonlesional epithelium (5.9%). Cyclin E positivity and/or HPV positivity was seen in 100% of the low-grade SILs. Epithelial Ki-67 and cyclin E staining were strikingly different in frequency and distribution. Cyclin E was undetectable in basal cells of normal mucosa (which were positive for Ki-67) and limited to suprabasal epithelium in noninvasive lesions. Cyclin E expression correlates strongly with morphologic features of HPV-related preinvasive and invasive cervical disease. This correlation is most pronounced in low-grade SILs. The possibility that in vivo cyclin E staining is a generic marker for HPV infection in low-grade SILs merits additional study.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872657

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS.

Authors:  Katerina Strati; Paul F Lambert
Journal:  Expert Opin Med Diagn       Date:  2008-01-01

2.  Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori-induced gastric precancerosis.

Authors:  Yong-Li Yao; Bo Xu; Yu-Gang Song; Wan-Dai Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 3.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

Review 4.  A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.

Authors:  Ralph P Insinga; Kai-Li Liaw; Lisa G Johnson; Margaret M Madeleine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

Review 5.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

Review 6.  Molecular basis for advances in cervical screening.

Authors:  John Doorbar; Heather Cubie
Journal:  Mol Diagn       Date:  2005

7.  The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions.

Authors:  M I Zubillaga-Guerrero; B Illades-Aguiar; M A Leyva-Vazquez; E Flores-Alfaro; E Castañeda-Saucedo; J F Muñoz-Valle; L C Alarcón-Romero
Journal:  J Cytol       Date:  2013-01       Impact factor: 1.000

8.  Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha; Kai-Li Liaw; Eliav Barr
Journal:  Infect Agent Cancer       Date:  2007-07-12       Impact factor: 2.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.